Research Article
Long-Term Follow-Up after Prostatectomy for Prostate Cancer and the Need for Active Monitoring
Table 5
Biochemical (PSA) failure, metastatic disease, prostate cancer death, and overall survival by risk groups.
| | Risk group (number) | Biochemical failure (%) | Metastatic disease (%) | Died of prostate cancer (%) | Died (%) |
| | Low (373) | 87 (23%) | 12 (3%) | 15 (4%) | 280 (75%) | | IM (112) | 56 (50%) | 6 (5%) | 8 (7%) | 91 (81%) | | High (96) | 69 (72%) | 18 (19%) | 21 (22%) | 87 (91%) | | Total (581) | 212 (36%) | 36 (6%) | 44 (8%) | 458 (79%) |
|
|
IM = intermediate.
|
